Scuttlebutt

Scuttlebutt

Strive Pharmacy CEO on the GLP-1 boom: "we've grown to over 1,100 employees"

11 lessons: why Strive never took outside money, potency tests run several times a week instead of once a year, and how far big pharma's lobbyists outnumber compounders

Scuttlebutt's avatar
Scuttlebutt
Nov 22, 2026
∙ Paid

Founder's Story · Nov 21, 2026 · 35m · 25m saved

With Nate Hill, CEO and Co-Founder of Strive Pharmacy

Strive Pharmacy CEO on the GLP-1 boom: "we've grown to over 1,100 employees"

Strive Pharmacy had about 100 employees when demand for GLP-1 drugs took off, and more than 1,100 three to four years later. Nate Hill, CEO and co-founder of the compounding pharmacy, told Daniel Robbins on Founder's Story that Strive paid for that growth without ever taking outside investment.

Most companies that grow that fast raise money to do it. Nate and his co-founder, Mike, a pharmacist, kept the equity instead, partly because the regulatory future of compounding looked so uncertain when they started. The growth that followed broke almost every system the company had.

"I'd say everything broke. Everything broke from our onboarding of our customers to our capacity to the process of how we dispense the medications." — Nate Hill

Nate spent his summers selling door to door on 100% commission before moving into pharmaceutical sales, where he watched drugmakers sell one drug to treat the side effects of another. He has since gone to Washington to lobby for compounding pharmacies against an industry with far more lobbyists than his own.

The full interview is covered here so you can skip it. 35 minutes of audio, 10 minutes of reading.

Here are the 11 lessons that matter.


This Scuttlebutt Summary is available in full to premium subscribers. If you're not one already, please consider subscribing to keep reading.


Key Takeaways

  • Strive went from about 100 employees to over 1,100 in three to four years of GLP-1 demand

  • Strive never took outside investment, partly because the rules for compounding looked uncertain

  • When demand hit, "everything broke", from customer onboarding to dispensing

  • Nate says compounded GLP-1s are often different doses or formulations, not copies of commercial drugs

  • Research-use-only peptides sold at gyms and on social media carry no accountability for what is in them

  • Strive runs potency tests multiple times a week where the rules ask for once or twice a year

  • Nate's hardest lesson is that revenue follows honest business, not the other way around

1. Two Founders, Zero Investors

Strive began as two people with two jobs. Mike, a pharmacist, made and shipped the medications, and Nate, who came from sales, brought in the prescriptions.

Strive started with one pharmacist and one sales rep

"When we started the company, it was just the two of us, myself and my co-founder, Mike, who was a pharmacist... you can be the pharmacist and I'll be the sales rep and I'll drive business to the pharmacy and you'll fill them and take the prescriptions and make the medications and ship them out." — Nate Hill

The split followed their skills: Mike's pharmacy expertise and business sense, and Nate's sales background. Nate credits that division with holding the partnership together through its "ups and downs."

Nate says uncertainty over compounding rules was one reason to keep the equity

"I think starting out on our first venture, there was just a lot of things that were unknown. We're also going into an industry that there's been a lot of uncertainty around when it comes to compounding and the regulations." — Nate Hill

In Nate's account, the founders felt they didn't need outside investment to get the business off the ground. With the industry's future unclear, they wanted to own as much of the company as they could.

2. Eight Years Before the Rush

User's avatar

Continue reading this post for free, courtesy of Scuttlebutt.

Or purchase a paid subscription.
© 2026 The Golden Age LLC · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for writing, podcasting, and media founders.